FROM DEATH BY VACCINATION ~ CLICK HERE
If you are a physician in need of further INFORMATION, including a recovery protocol,
you may call Lloyd Phillips at 336-600-1055, or EMAIL: PPL@Mailbox7.net
Gardasil Syndrome, a.k.a. Vaccine Syndrome, a.k.a. Gulf War Syndrome, a.k.a. Phillip-Offit-Wakefield Syndrome, with similar symptoms found in Lyme Disease and Autism: Top Symptoms:
1) Fatigue; 2) Pain: headache, stomach, or joints; 3) Lightheadedness upon standing (POTS); 4) Flares of inflammation, nausea, and Lupus-like symptoms plus possible Ankylosing Spondylitis if HLA-B27 gene mutation is PRESENT; 5) Irritability & Short Temper; 6) Memory Loss & Inability to concentrate; 7) Increased sensitivity to light and/or loud sounds, smells, foods; 8) Eczema, acne, hives, rashes, ITP; 9) Multiple Vector-borne pathogens, such as Lyme-related infections and co-infections may typically be present; 10) Unskilled doctors may typically tell you it’s all in your head (Conversion Disorder); 11) Histamine Intolerance, Irritable Bowel Syndrome, Gastroparesis, plus Thyroid and Gallbladder disorders have been observed when left untreated.
Tests Required: 1) Comprehensive Cytokine Panel (NeuroScience Panel #5086); look for LPS Stimulated Cytokines to be typically greater than 50% below gate; 2) LabCorp #HNK1. NK-CD57 counts will typically be FAR BELOW gate (absolute counts greater than or equal to 63), with many absolute count results falling at or below 22
Four Year Analysis of Adverse Reactions to the Gardasil HPV Vaccine
by Lloyd W. Phillips
Copyright ©2013 Lloyd W. Phillips
Prolonged inflammation initiated by powerful vaccine adjuvants such as Amorphous Aluminum Hydroxyphosphate Sulfate (AAHS), may be life-threatening and/or result in cognitive and motor skill disorders in those individuals with multiple genetic mutations which affect:
1) Transsulfuration (such as CBS 699t),
2) Glutathione production and utilization (such as GSTM1), and
3) Pathogen Load (such as HLA-DR15).
Although other mutations may contribute to the cascade of debilitating events, such as C282Y, which is associated with Hemochromatosis, the above three genetic conditions formed the core group in this study.
Concomitant (multiple) vaccinations may increase the severity of adverse reactions.
Physical ACTIVITY as a Risk Factor for an Adverse Vaccine Reaction
We observed that children who appeared to be very healthy prior to receiving the Gardasil HPV vaccine, and were the most physically active following the vaccination (PARTICIPATED in sports, cheerleading, dancing, biking, skating, or other physical activity), suffered the most severe debilitating symptoms, possibly due to the increased distribution of the vaccine throughout their body due to increased circulation from exercise.
Syncope / Fainting
We observed that Syncope (fainting), following the Gardasil HPV vaccine, may be the result of an acute allergic reaction. Dr. L.C., received the Gardasil HPV vaccine in 2006 while attending medical school. She returned to class after receiving the HPV vaccine, and lost consciousness. Her vitals were taken, and it was documented that her BLOOD PRESSURE had plummeted to a life-threatening 50/32. We hypothesize this “fainting” was due to an acute allergy-related response to the yeast associated components in the vaccine, which resulted in a massive histamine release from eosinophils and mast cells. This elevated histamine quickly dilated blood vessels, and appears to be the cause for the drop in blood pressure. We suspect that these children may not have been properly screened for an allergy to mold and other members of the Fungal Kingdom. Fortunately she did not drive home after her vaccination and die in a car crash. Warnings were not issued until three years later (2009).
Head Pressure (acute)
The majority of children who develop debilitating and/or life threatening conditions reported severe head pressure within one or two hours of receiving the HPV vaccine. Those who received concomitant vaccines appeared to have a quicker onset of new medical conditions after just one or two HPV vaccinations.
Vitamin D levels appear to plummet (25 Hydroxy Vitamin D) in this group following the administration of the Gardasil HPV vaccination.
Intracellular magnesium quickly becomes depleted following administration of the Gardasil HPV vaccine. However, serum magnesium typically remains on the low side of lab normal.
Magnesium and the “Fight or Flight” Response
Our findings indicate that the immune system may not be capable of distinguishing between fear and the inflammation caused by aluminum adjuvants in modern vaccines. Both events were observed to trigger the “Fight or Flight” response, which forced the subject to excrete magnesium.
The human body uses magnesium in the production of about 300 different enzymes. When intracellular (within the cell) magnesium becomes depleted, it is virtually always missed by doctors who look at serum (blood) magnesium. Every cell in the body will contribute its last bit of magnesium to keep the heart pumping. We observed multiple symptoms of a magnesium deficiency: muscle jerks and spasms; pain; irritability; newly acquired panic disorders; heart arrhythmias; headache; and more. Low magnesium may result in personality changes and irritability. One mother described her daughter as the “she bitch from hell” since receiving the Gardasil HPV Vaccine.
Since many cycles fail (methylation, H3K4 Trimethylation, etc.), we observed that it was necessary to administer some vitamins in their active form to maintain proper serum levels. This was especially true of Vitamins B6 and B12.
Symptoms of Vitamin B1 Deficiency (Beriberi): Thiamine tetrahydrofurfuryl disulfide
Although many of the subjects received Vitamin B1 supplements, we observed many symptoms of a Vitamin B1 (Thiamine) Deficiency. Thiamine is involved in a variety of glucose metabolism-related and neurological functions, including the making of myelin. Many symptoms of the B1 Deficiency decreased when Thiamine tetrahydrofurfuryl disulfide (TTFD) was administered. Allithiamine is one alternative name for TTFD, a fat-soluble form of Vitamin B1.
We acknowledge the observed genetic deficit(s) in the Transsulfuration Cycle due to the CBS gene, and confirm the findings of DETH R et al, Thomson, and others who documented that oxidative stress plays a critical role in the utilization of Thiamine in the human body.
Genetics and Pathogens
The Human Leukocyte Antigen (HLA) Serotype was present in most who were tested. The HLA-DR15 mutation was found in those most seriously affected. Those with HLA-DR15 appeared acutely sensitive to mold, and exposure would cause a re-emergence of debilitating symptoms.
Genetics and Transsulfuration
Many tested positive for the CBS Gene, and were not able to properly process sulfur. The Cystathionine Beta-Synthase gene, especially the CBS 699t genetic mutation, appeared to be causing a life-threatening cascade of events in these patients, and we observed the following sulfur-related symptoms:
- Low Glutathione – Sulfur is required for Glutathione synthesis. ALL who were tested had low glutathione levels.
- Connective Tissue Disorders – Sulfur is responsible for Collagen Synthesis, and lack of sulfur leads to poor tissue (skin) structure and strength.
- Inflammation – low sulfur can lead to the progression of inflammation and degenerative disorders
Note: Medical Practitioners should be aware that an infant or toddler who screams for prolonged periods, or any child who bangs their head, may actually be signaling that they are experiencing a breakdown in the TRANSSULFURATION Pathway (CBS Gene). When sulfur is not properly metabolized, EXCRUCIATING HEAD PRESSURE may result when sulfites enter the brain and produce acute pain. You should always be on guard that a migraine may be a warning sign of a CBS Gene mutation, especially CBS 699t.
Sulfur-related sustained inflammation, especially involving inflamed glial cells in the brain, may affect nearby Oligodendrocytes, which may then inhibit myelin production, and result in demyelinating disorders, such as Multiple Sclerosis.
Medical practitioners and caregivers, including parents with the best intentions, may do more harm by attempting to treat symptoms of impaired transsulfuration. An example is totally removing dietary fruits and vegetables necessary for the prevention of damage caused by oxidative stress, in an attempt to lower oxalates, instead of taking measures to improve transsulfuration.
A significant number of female subjects developed Interstitial Cystitis, including many months after they appeared to be feeling better. We suspect, but cannot confirm, that the failure of the transsulfuration cycle may have contributed to this condition.
Histamine Intolerance and Sustained Inflammation
We have observed that the majority of subjects developed a Histamine Intolerance, which resulted in self-sustained inflammation. This Histamine Intolerance was not present prior to the Gardasil HPV vaccine, nor was any indication of Mastocytosis.
We took note of the extensive research done by Husheng Li et al., at the University of Tennessee, Knoxville, into how aluminum vaccine adjuvants activate caspase-1 and induce IL-1beta and IL-18 release. We hypothesize that the release of IL-1beta and Interleukin-18 (and possibly other pro-inflammatory cytokines), may have inflamed the gut and caused a breakdown of the mucosal lining. This appears to have allowed immune cells in the lining of the gut to come into contact with food proteins as they traveled through the gut. The immune cells appear to have made antibodies to some foods, and when these foods were again eaten at a later date, the immune system appeared to treat these food proteins as allergens, and trigger mast cells to produce histamine. We observed that the majority of these children and adults felt lightheaded upon standing. We hypothesize that the elevated histamine, caused by this newly acquired histamine intolerance, dilated blood vessels, and significantly lowered blood pressure to the brain. We further hypothesize that this may be the cause, or a contributing factor to Postural Orthostatic Tachycardia Syndrome (POTS).
We observed that this newly formed histamine intolerance and resulting self-sustaining inflammation did not subside until foods containing moderate to high amounts of histamine were removed from the diet. We observed that Low Dose Naltrexone was beneficial for this condition, and it also helped relieve insomnia.
Insomnia was present in the majority of the subjects. We attribute this to the pineal gland possibly being inhibited by cortisol as a result of inflammation, including inflammation associated with the newly acquired histamine intolerance.
Pathogens and Body Burden
The most common enterovirus we observed was Epstein Barr Virus (EBV). EBV can act as an incubator for other pathogens and infect fast-growing cytokines when inflammation is present. A previous history of Mononucleosis (Glandular Fever) was virtually a 100% predictor of a life-threatening adverse reaction to the Gardasil HPV vaccine, and similar results were observed among families of autistic children.
Only one out of approximately 100 families observed or interviewed was eventually diagnosed with Chronic Active Epstein Barr (CAEBV)
Vector borne pathogens such as Bartonella, Borrelia Burgdorferi (Lyme Disease), Mycoplasma Pneumoniae, Babesia, and FL1953 (Protomyxzoa Rheumatica), were the most commonly observed pathogens. Several of these would typically be found together in the children who were tested. Bartonella was never found alone.
Note: NK-CD57 counts typically ranged between 8 and 51, with the majority falling at or below 22.
A history of Mycoplasma/Mycoplasma Pneumoniae, Acne Vulgaris (which can turn Interleukin-10 into Viral Interleukin-10 (vIL10)), and eczema were identified as risk factors for an adverse event. Interleukin-10 is associated with controlling inflammation.
Several girls became pregnant during this four year study, and in each case their symptoms subsided for the length of the pregnancy. We hypothesize that elevated levels of Interleukin-10, released during pregnancy, attenuates inflammation, which is key to this syndrome.
- Insult to immune system, typically a vaccination, may cause inflammation
- Inflammation triggers the Fight or Flight response
- The Fight or Flight response causes magnesium to be excreted
- Inhibition of ~300 magnesium-dependant cycles
- Failure of transsulfuration cycle results in inhibited sulfur-dependant cycles such as those responsible for glutathione, collagen and connective tissue, control of inflammation, etc.
- When gene mutations are present, low cycle output may result in a cascade of debilitating or life-threatening events
- Dormant pathogens may become virulent
CLICK HERE FOR PRODUCT REPORT FROM MERCK PHARMACEUTICALS REGARDING GARDASIL
(Reuters) – Dr. Julie Gerberding, former director of the Centers for Disease Control and Prevention, was named president of Merck & Co Inc’s vaccine division, the company said on Monday.
Gerberding, who led the CDC from 2002 to 2009, stepped down when President Barack Obama took office.
She had led the agency from one crisis to another, including the investigation into the anthrax attacks that killed five people in 2001, the H5N1 avian influenza, the global outbreak of severe acute respiratory syndrome, or SARS, and various outbreaks of food poisoning.
“As a preeminent authority in public health, infectious diseases and vaccines, Dr. Gerberding is the ideal choice to lead Merck’s engagement with organizations around the world that share our commitment to the use of vaccines to prevent disease and save lives,” Merck Chief Executive Officer Richard Clark said in a statement.
“I am very excited to be joining Merck where I can help to expand access to vaccines around the world,” added Gerberding, who will head up the company’s $5 billion global vaccine business that includes shots to prevent chickenpox, cervical cancer and pneumonia.
STAGE 2 after vaccines
GMO INSULIN TEST
Diabetics not told of Insulin RiskPaul Brown / Guardian UK 9mar99
Report highlighted coma dangers to 15,000 sufferers who were switched to genetically-engineered human substitute:
Evidence that thousands of diabetics in Britain may have suffered a deterioration in their health from genetically-engineered insulin has been withheld by the British Diabetics Association, whose role is to advise patients and to protect their interests.
The evidence was contained in a report, commissioned by the association and completed in 1993, which highlighted dangers faced by about 10 per cent of the 150,000 diabetics who had been switched from the traditional animal-derived insulin to genetically-engineered human insulin.
Some adversely affected began, without warning, to go into comas, known as hypoglycaemic episodes or ,hypos”. Same suffered severe injuries, a few crashed their cars, and others believed they would have died had they not been rescued as they lay unconscious. An estimated 15,000 people may still suffer because they are injecting themselves twice a day with insulin that may not suit them.
Many doctors are unaware of the problem, or have failed to put their patients back on animal insulin because they do not know it is still available. The association says it did not publish the report because it was ,,too alarmist”. Simon O’Neill, head of diabetes care services, said the association agreed that up to 20 % of insulin injectors preferred animal insulin and had experienced difficulties with genetically-engineered insulin. He added that the association had published a report, The Insulin Debate, which kept members informed of developments, and campaigned to keep animal insulin available to sufferers.
Genetically-engineered insulin is manufactured by the drug companies, the Danish Novo Nordisk and Elli Lilly. Neither accepts that the genetically-engineered version has negative effects.
The report was compiled following 3,000 letters of complaint over two years about the new insulin from association members. The letters told how lives had deteriorated after being switched to genetically-engineered human insulin. Eight out of 10 of a sample of the complainants examined by independent researchers said they could no longer control their symptoms and had lost warning signs of impending comas. The main conclusions from the letters were:
- Half the patients had no warning of passing out with hypos once on the new drug.
- A quarter said such episodes were more frequent, and one in five said they were more severe.
- Thirteen per cent said they became unconscious at night and 5 per cent suffered convulsions.
- Ten per cent had memory loss and another 9 percent were unable to concentrate.
Matthew Kiln a south London GP who is an expert on diabetes, was a member of the committee of inquiry set up by the association that looked into the side-effects of genetically-engineered human insulin. He told the Guardian: “The association has failed in its duty to protect and represent the interests of diabetics by not publishing the committee’s findings in full. I and other doctors who understand this issue have been quietly switching some patients back to animal Insulin to avoid the problems but thousands of people are suffering from lack of choice.”
Dr. Kiln is himself a diabetic who uses insulin and has experienced the negative effects when he switched to the genetically-engineered version. Before genetically-engineered human insulin was introduced in the early 1980s around 150,000 diabetics in Britain injected themselves twice a day with insulin extracted from pigs and cattle in slaughterhouses. Diabetes is the result of the body’s inability to produce insulin which regulates blood sugar levels but it can be successfully managed by injecting animal insulin. Genetically-engineered human insulin, made from feeding nutrients to E-coli bacteria, was heralded as a breakthrough because it would avoid an occasional long term problem of antibodies being produced to combat animal insulin.
After the association received a tide of complaints, it commissioned two independent researchers, Hazel Matthews and Natasha Posner, to analyse some of the letters. Their report concluded that many patients were suffering potentially dangerous reactions. A fuller report ordered from Dr Posner concluded that doctors and specialists had failed to listen to patients and the distress and dangerous symptoms had been largely ignored. The report was due to the published in the British Medical Journal in 1993 but was withdrawn. The Diabetic Association’s Journal, Balance, subsequently produced a supplement, The Insulin Debate, in which some of the problems of genetically-engineered insulin were discussed. O’Neill said the BDA continued to educate medical staff of the need to give diabetics the option of using animal insulin. He said: “The message of the Posner report was right, it was just too alarmist, but it is a message we have disseminated. It is a message we’re still trying to get out. We’ve campaigned to stop animal insulin being withdrawn. Matt Kiln and we are on the same side.”
The 3,000 letters of complaint written to the British Diabetic Association by patients, their relatives and doctors concerned the deterioration in their condition since being moved from animal insulin to genetically-engineered human insulin. After analysing nearly 400 of the letters, Natasha Posner, an independent researchers commissioned by the DBA, said: “Many correspondents reported that a diabetic condition which had been stable and controlled over many years and allowed a full and normal Iife, suddenly changed and became problematic and life disrupting. For people experiencing these difficulties, the cost in terms of immediate negative effects far out-weighed any possible long term benefits of this new insulin.”
The report says that in many cases where the patient had complained, the relationship between the diabetic and doctor was breaking down and there was a potential for conflict because the patient felt his fears had been ignored.
The single most important complaint was the sudden onset of comas. A second problem was personality changes, mostly noticed by partners and colleagues. A third, and of great concern to the association, was a breakdown in relationship between the diabetics who manage their illness, and the professionals who advise them and prescribe their insulin.
There was also strong evidence that the problems were reversible. One fifth of the patients in the survey switched back to animal insulin. Of these only 1 per cent said there was no improvement when they returned to animal insulin. Many doctors refused to change them back or told them erroneously there was no longer an animal alternative.
“Correspondents reported the consequences of loss of control of the diabetes, deterioration in general health or accidents meant increased dependence an others and loss of confidence about controlling the diabetes so that there was fear of going out alone, going to bed or driving.”
“Some people had lost their job, been made redundant or found that they were unable to work. A few had been refused renewal of their driving licences. There were several reports of people who had been prosecuted by police after being involved in accidents while having a hypo,” the report said. The report concludes:”The letters examined constitute a source of data which amount to very much more than mere anecdotes.”
Patients’ comments were directly quoted in the report:
“While I was an human insulin, my life was absolute hell. There was absolutely no warning of my blood sugar going low, and I have been in several comas because of this. My cIinic put me back an to animal insulin in July, and I have felt a different person since.”
“It was only when I went an to human insulin that I thought I was not in control of my diabetes, I went into hypos almost daily with no warning whatsover (thanks to paramedics and good neighbours plus the casualty department at the local hospital I am still here to tell the tale).”
One patient reported that his family noticed: “The complete change of character. I was becoming moody critical, confused, forgetful and seemed to lack concentration. But more and more I seemed to have unnoticed hypos.”
From a wife: “There is no doubt in my mind that had be been living alone he would now be dead, Many of the hypos occur during the night for no reason.”
From a mother “The clinic argues that the human insulin is better for him in the long run than animal insulin – that is if he can survive.”
USA 1999: “Enforced switch to human insulin worries some diabetics“
After manufacturing stopp by Eli Lilly of their beef/pork mixed insulin ILETIN I – see under “Things look grim in the USA 1997″ – human insulin victims report in the Journal of the American Medical Association
JAMA 1999; 281:121-122., i.e.:
“… The results with human based insulin were disastrous. The changes in my overall feeling of well-being were immediat. The experience I had with Humulin was negative overall, ranging from loss of what had been relatively good diabetic control, to feeling strange in general, to experiencing the more serious hypoglycemic unawareness episodes. In 20-plus years with diabets I had never lost consciousness because of hypoglycemic reaction until I switched from ILETIN I to Humulin.”…
The American Diabetes Association (ADA) asked about their concerns, that there may be an increase this summer of “dead in bed syndrome” facing diabetics their chief scientific and medical officer said:
“We’re a little nervous, but biologically there should be no reason why you can’t switch over…”
Meanwhile are the “Tips for Easing the Transfer to Human Insulin” by Eli Lilly and Company at the end of the article not reassuring any animal insulin dependent diabetic!
IDDT (Insulin Dependent Diabetes Trust) UK and USAare dedicated to the preservation of range and variety in insulins for those who use it: For more information and what you can do look at:
1997: Things look grim in the USA: “Lilly Beef/Pork Insulin on the Endangered Species List”:
Eli Lilly, the manufacturer of 80 % of America’s insulin is planning to take ILETIN I (beef/pork) insulins off the market. Lilly has made no formal public announcement of these plans, but since May of this year anyone who calls Lilly’s customer service line (800-545-5979) is politely informed that, “Production will cease in 1998, and it is expected that the stock will be completely depleted some time in 1999.”
What does that mean for the estimated 300,000 in the United States who depend on ILETIN I ?… starts on the front page of Diabetes Interview (October 1997) a report about a number of controversial issues surrounding the Lilly decision. Three National Diabetes Organizations provide statements on animal insulin: The Canadian (CDA), British (BDA) and American (ADA) Diabetes Associations:
As the CDA states : “Our survey results indicate that for some people, changing insulins has a negative impact on their health, well-being and quality of life… ” and “CDA is committed to advocating for the continuation of beef/pork insulins for those who will be affected by the switch to human insulin… ”
The BDA notes: “A sizeable minority of people prefer animal insulins and claim human insulin causes them to experience loss of warning signals for hypoglycemia, though, BDA argues ther is no direct evidence from clinical research of such a link.” … “Quite clearly, however, a lot of people have concerns and feel happier on animal insulins and the BDA supports their right to chose the insulin that suits them best”. ADA recognizes: “… patients’ concern with the discontinuation of mixed beef/pork insulin production in the United States.” “… The ADA acknowledges that human insulin will inevitably replace all forms of animal insulin …”
The Editor in Chief ends up with “My own injection”:
“Who is going to advocate for those people in the United States whose health, well-being or quality of life will be affected by the enforced change to human insulin? This is of special concern because unlike Britain and Canada, the US have no socialized medicine. Many here won’t have a doctor who is able to coach them through the significant changes in lifestyle and dosing that accompany an insulin species transfer!”
Find Diabetes Interview on : http://www.diabetesworld.com
You need to be a member of 12160 Social Network to add comments!
Join 12160 Social Network